| Application no. and date | 20753563.4 (espacenet) (Federated) (European Patent Register), 20200716 | | Patent/reg. no. and date | DK/EP 3999038, 20240110 | | Publication date | 20220525 | | Priority no. and date | US 201962875358 P, 20190717 | | EP pub. no. and date |
EP 3999038 20220525 | | Effective date | | | Applicant/owner | Cytokinetics, Inc., 350 Oyster Point Blvd
South San Francisco CA 94080, US | | Applicant ref. no. | P83841DK01 | | Inventor | QIAO, Chunsheng, 730 Layne Court
Palo Alto, California 94306, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/4178 (2006.01) , A61K 9/16 (2006.01) , A61K 9/20 (2006.01) , A61K 9/28 (2006.01) , A61P 9/04 (2006.01) | | Title | ORALE FORMULERINGER AF EN KARDIAL SARCOMER-INHIBITOR | | Int. application no. | US2020042389 | | Int. publication no. | WO2021011808 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
